Retrospective analysis of safety in elderly BRAF V600 mutation-positive advanced melanoma patients treated with dabrafenib (D) and trametinib (T) and correlation with non-elderly patients

被引：0

作者：

Garcia-Castano, A. ^{[1
]}

Gonzalez-Barrallo, I. ^{[2
]}

Castellon Rubio, V. E. ^{[3
]}

Medina Martinez, J. ^{[4
]}

Manzano Mozo, J. L. ^{[5
]}

Mujika, K. ^{[6
]}

Majem Tarruella, M. ^{[7
]}

Aguado de La Rosa, C. ^{[8
]}

Cabrera Suarez, M. A. ^{[9
]}

Palacio, I. ^{[10
]}

Osterloh, L. ^{[11
]}

Martinez Fernandez, A. ^{[11
]}

机构：

[1] Hosp Univ Marques de Valdecilla, Med Oncol, Santander, Spain

[2] Hosp Clin Univ Valencia, Med Oncol, Valencia, Spain

[3] Hosp Univ Torrecardenas, Med Oncol, Almeria, Spain

[4] Hosp Virgen de la Salud, Med Oncol, Toledo, Spain

[5] Germans Trias & Pujol Univ Hosp HUGTiP, Badalona Appl Res Grp Oncol B ARGO, Catalan Inst Oncol ICO Badalona, Med Oncol, Badalona, Spain

[6] UGC Oncol Gipuzkoa HU Donostia Onkol, Med Oncol, Donostia San Sebastian, Spain

[7] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain

[8] Hosp Clin Univ San Carlos, Dept Med Oncol, Madrid, Spain

[9] Hosp Univ Nuestra Senora Candelaria, Med Oncol, Santa Cruz De Tenerife, CA, Spain

[10] Hosp Univ Cent Asturias, Med Oncol, Oviedo, Spain

[11] Novartis Farmaceut SA, Med Affairs, Barcelona, Spain

来源：

关键词：

D O I：

10.1016/j.annonc.2020.08.1241

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1118P

引用

页码：S753 / S753

页数：1